Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Gastroenterol. Mar 21, 2026; 32(11): 115393
Published online Mar 21, 2026. doi: 10.3748/wjg.v32.i11.115393
Published online Mar 21, 2026. doi: 10.3748/wjg.v32.i11.115393
LIM domain only protein 7 promotes metastasis in colorectal cancer by TGF-β/ZEB1 pathway
Xue Bai, Xue-Mei Li, Xia Chen, Department of Gastroenterology, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu 610500, Sichuan Province, China
Xue Bai, Xue-Mei Li, Xia Chen, Key Laboratory of Digestive Microecology Medicine of Sichuan Health Commission, Chengdu 610500, Sichuan Province, China
Xue Bai, Xue-Mei Li, Xia Chen, Key Laboratory of Digestive System Tumors and Microenvi ronment of Sichuan Provincial University, Chengdu 610500, Sichuan Province, China
Bo Zheng, Juan-Dan Wang, Xiao-Hua Huang, Shu-Mei Fu, Department of Gastroenterology, Affiliated Hospital of Sichuan Nursing Vocational College (The Third People's Hospital of Sichuan Province), Chengdu 610100, Sichuan Province, China
Co-first authors: Xue Bai and Bo Zheng.
Author contributions: Bai X and Zheng B performed formal analysis and investigation as co-first authors; Li XM, Wang JD, Huang XH and Fu SM performed data curation; Chen X was responsible for supervision, project administration and funding acquisition, wrote the original draft; all authors contributed to conceptualization, methodology and review, read and approved the final manuscript.
Supported by The First Affiliated Hospital of Chengdu Medical College, No. CYFY-GQ47; Health Commission of Chengdu, No. 2024253; Chengdu Medical College, No. 24LHXHZW1-04; and Project of “CMC Talents” Peak Plan of Chengdu Medical College, No. 2024kjTzn06.
Institutional review board statement: Sample collection and research were approved by the Ethics Committee of the First Affiliated Hospital of Chengdu Medical College (No. 2023CYFYIRB-BA-Feb001), and strictly adhered to the ethical principles outlined in the 2013 revised version of the World Medical Association Declaration of Helsinki for human-related research.
Institutional animal care and use committee statement: All animal experimental protocols were approved by the Laboratory Animal Welfare and Ethics Committee of Chengdu Medical College (No. 2023056), and were performed in accordance with GB/T 35892-2018 (Guidelines for Welfare and Ethical Review of Laboratory Animals) and the ARRIVE Guidelines. Animals were housed in a specific pathogen-free facility to ensure compliance with animal welfare standards, minimizing stress and suffering during the experiment.
Conflict-of-interest statement: All authors declare no conflict of interest in publishing the manuscript.
ARRIVE guidelines statement: The authors have read the ARRIVE guidelines, and the manuscript was prepared and revised according to the ARRIVE guidelines.
Data sharing statement: The authors declared that all data supporting the conclusions of this research is available.
Corresponding author: Xia Chen, MD, Chief Physician, Professor, Department of Gastroen terology, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, No. 312 Baoguang Avenue Middle Section, Xindu District, Chengdu 610500, Sichuan Province, China. 970217858@qq.com
Received: October 20, 2025
Revised: November 22, 2025
Accepted: December 30, 2025
Published online: March 21, 2026
Processing time: 150 Days and 8.4 Hours
Revised: November 22, 2025
Accepted: December 30, 2025
Published online: March 21, 2026
Processing time: 150 Days and 8.4 Hours
Core Tip
Core Tip: LIM domain only protein 7 (LMO7) is upregulated in colorectal cancer (CRC), and is correlated with clinical stage and metastasis. It promotes CRC cell proliferation, migration, invasion, epithelial-mesenchymal transition and tumor metastasis. transforming growth factor-β induces LMO7 expression by upregulating zinc finger E-box binding homeobox 1, which binds to the LMO7 promoter, forming a transforming growth factor-β/zinc finger E-box binding homeobox 1/LMO7 axis that drives CRC progression, highlighting LMO7 as a potential therapeutic target for CRC.
